ABSTRACT Introduction The plasminogen activating (PA) system has a multitude of functions such as wound healing, proteolytic activity, collagen degradation and cell growth, and the role of the urokinase plasminogen activator/urokinase plasminogen activator receptor (uPA/uPAR) system has been studied in many disease states.
Ahmed Khudhur+6 more
wiley +1 more source
Using Rotational Thromboelastometry (ROTEM) to Evaluate Coagulation Status After Intrapleural Recombinant Tissue Plasminogen Activator (rtPA) Administration in Regional Anesthesia. [PDF]
DeLeon A+6 more
europepmc +1 more source
Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review. [PDF]
Chan C+6 more
europepmc +1 more source
Blood cells participate in the fibrinolytic response to tissue-type plasminogen activator [PDF]
MW Hammouda, LA Moroz
openalex +1 more source
Lysosomal cysteine proteinases as mediators of inflammation and tumor spread [PDF]
Assfalg-Machleidt, Irmgard+4 more
core +1 more source
Tissue Plasminogen Activator in Acute Cardiac Arrest. [PDF]
Acharya I, DeBoer SR, Haas CJ.
europepmc +1 more source
Production of monoclonal antibodies to the high fibrin-affinity, tissue- type plasminogen activator of human plasma. Demonstration of its endothelial origin by immunolocalization [PDF]
Eduardo Anglés‐Cano+5 more
openalex +1 more source
Use of recombinant tissue plasminogen activator (rTPA) for treatment of fibrin in the anterior chamber of the horse. [PDF]
Pereira R+5 more
europepmc +1 more source
Does Emergency Medical Services Blood Collection Shorten Time to Tissue Plasminogen Activator in Ischemic Stroke? [PDF]
Hulsizer AL, Davis S, Gibson CM.
europepmc +1 more source
Therapeutic options for human papillomavirus‐positive tonsil and base of tongue cancer
Abstract The incidences of human papillomavirus‐positive (HPV+) tonsillar and base tongue squamous cell carcinomas (TSCC and BOTSCC) have increased in recent decades. Notably, HPV+ TSCC and BOTSCC have a significantly better prognosis than their HPV‐negative counterparts when treated with current surgical options, radiotherapy, or intensified ...
Mark Zupancic+3 more
wiley +1 more source